prednisone has been researched along with Chronic Inflammatory Demyelinating Polyradiculoneuropathy in 39 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe two cases of CIDP secondary to treatment with combined ipilimumab and nivolumab in patients with metastatic melanoma that were successfully treated with prednisone and IVIG." | 3.91 | Chronic inflammatory demyelinating polyradiculoneuropathy secondary to immune checkpoint inhibitors in melanoma patients. ( Patel, AS; Sehdev, A; Snook, RJ, 2019) |
| " The treated group was administered with GTC and prednisone, while the control group with prednisone alone." | 2.74 | [Clinical observation on treatment of 10 patients with chronic inflammatory demyelinating polyneuropathy by gullong tongluo capsule combined with prednisone]. ( Chen, JL; Hu, JY; Zhang, ZH, 2009) |
| "Inflammatory peripheral neuropathies can be disabling for any patient." | 2.72 | Immunotherapy for Peripheral Nerve Disorders. ( Granger, A; Zakin, E, 2021) |
| "Eighteen of them also had monoclonal gammopathy of undetermined significance (MGUS)." | 2.69 | Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients. ( Ciano, C; Fallica, E; Mariotti, C; Pareyson, D; Sghirlanzoni, A; Solari, A, 2000) |
| "Chronic inflammatory demyelinating polyradiculoneuropathy is an inflammatory disorder of nerve that usually presents with slowly progressive weakness and sensory loss and areflexia." | 2.42 | The treatment of chronic inflammatory demyelinating polyradiculoneuropathy. ( Kissel, JT, 2003) |
| "Chronic inflammatory demyelinating polyradiculoneuropathy is an autoimmune peripheral neuropathy and would be expected to benefit from corticosteroids." | 2.41 | Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. ( Hughes, RA; Mehndiratta, MM, 2001) |
| "Chronic inflammatory demyelinating polyradiculoneuropathy is a peripheral neuropathy caused by peripheral nerve inflammation probably due to autoimmunity and would be expected to benefit from corticosteroids." | 2.41 | Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. ( Hughes, RA; Mehndiratta, MM, 2002) |
| "Patients with CIDP respond adequately to steroid therapy and intravenous immunoglobulin (IVIG)." | 1.62 | Efficacy of long-term prednisone therapy in patients with chronic inflammatory demyelinating polyneuropathy (CIDP): a retrospective cohort study. ( Galnares-Olalde, JA; López-Hernández, JC; Mercado-Pompa, A; Pérez-Torres, T; Vargas-Cañas, ES, 2021) |
| "Seven clinically suspected CIDP patients who did not fulfill EFNS/PNS electrodiagnostic criteria for demyelinating neuropathy were enrolled in our study." | 1.48 | Diagnosing chronic inflammatory demyelinating polyradiculoneuropathy with triple stimulation technique. ( Cao, D; Guo, X; Hao, J; Yuan, T, 2018) |
| " Outcomes were number of responders to treatment, remission rate of treatment responders, overall probability of 5-year remission, and the occurrence of adverse events." | 1.48 | Corticosteroids in chronic inflammatory demyelinating polyneuropathy : A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone. ( Basta, I; Doneddu, PE; Eftimov, F; Gallia, F; Nikolic, A; Nobile-Orazio, E; Peric, S; van Lieverloo, GGA; van Schaik, IN; Verhamme, C; Wieske, L, 2018) |
| "The patient had initially a sensory CIDP wich respond to prednisone." | 1.34 | [Chronic inflammatory demyelinating polyneuropathy (CIDP) revealing an associated disease diagnostic and therapeutic pitfalls]. ( Jaccard, A; Maisonobe, T, 2007) |
| "We present 4 patients with CIDP who required respiratory assistance and mechanical ventilation." | 1.33 | Chronic inflammatory demyelinating polyneuropathy and respiratory failure. ( Henderson, RD; Sandroni, P; Wijdicks, EF, 2005) |
| "The ataxic form of chronic inflammatory demyelinating polyradiculoneuropathy (ataxic-CIDP) has been recently described as a subtype of chronic ataxic neuropathy, distinguished by steroid responsiveness and relative preservation of myelinated fibres at sural nerve biopsy." | 1.33 | Hyperpyrexia-triggered relapses in an unusual case of ataxic chronic inflammatory demyelinating polyradiculoneuropathy. ( Bertolasi, L; Ferrari, S; Mazzucco, S; Mezzina, C; Rizzuto, N; Tomelleri, G, 2006) |
| "Current electrodiagnostic criteria for CIDP are insensitive and may fail to diagnose the condition in a substantial number of patients." | 1.32 | Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy. ( Brannagan, TH; Chin, RL; Latov, N; Magda, P; Sander, HW; Weimer, LH, 2003) |
| "The oedema was not explained by immobility, hypoproteinaemia or local factors." | 1.31 | Chronic inflammatory demyelinating polyradiculoneuropathy and severe peripheral oedema: a renal explanation. ( Healy, HG; Henderson, RD; Lander, CM; McCombe, PA, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 22 (56.41) | 29.6817 |
| 2010's | 12 (30.77) | 24.3611 |
| 2020's | 5 (12.82) | 2.80 |
| Authors | Studies |
|---|---|
| López-Hernández, JC | 1 |
| Mercado-Pompa, A | 1 |
| Pérez-Torres, T | 1 |
| Galnares-Olalde, JA | 1 |
| Vargas-Cañas, ES | 1 |
| Patel, AS | 1 |
| Snook, RJ | 1 |
| Sehdev, A | 1 |
| George, IC | 1 |
| Kvalsund, M | 1 |
| Saylor, D | 1 |
| Rogers, AB | 1 |
| Zaidman, CM | 1 |
| Connolly, AM | 2 |
| Granger, A | 1 |
| Zakin, E | 1 |
| Hughes, RA | 6 |
| Mehndiratta, MM | 5 |
| Rajabally, YA | 1 |
| Shigemoto, R | 1 |
| Anno, T | 1 |
| Ohnuki, E | 1 |
| Kosaka, S | 1 |
| Okimoto, N | 1 |
| Kaku, K | 1 |
| Kaneto, H | 1 |
| Cao, D | 1 |
| Guo, X | 1 |
| Yuan, T | 1 |
| Hao, J | 1 |
| van Lieverloo, GGA | 1 |
| Peric, S | 1 |
| Doneddu, PE | 1 |
| Gallia, F | 1 |
| Nikolic, A | 1 |
| Wieske, L | 1 |
| Verhamme, C | 1 |
| van Schaik, IN | 2 |
| Nobile-Orazio, E | 1 |
| Basta, I | 1 |
| Eftimov, F | 1 |
| Russo, F | 1 |
| Vispi, M | 1 |
| Bocci, S | 1 |
| Mancini, V | 1 |
| Sirna, R | 1 |
| Giannini, F | 1 |
| Pellegrino, M | 1 |
| Herrera, I | 1 |
| Kam, Y | 1 |
| Whittaker, TJ | 1 |
| Champion, M | 1 |
| Ajlan, RS | 1 |
| Taylor, T | 1 |
| Netherton, SJ | 1 |
| Owen, CJ | 1 |
| Zochodne, DW | 1 |
| Kararizou, E | 1 |
| Anagnostou, E | 1 |
| Kapaki, E | 1 |
| Davaki, P | 1 |
| Oaklander, AL | 1 |
| Lunn, MP | 1 |
| Frost, C | 1 |
| Chalk, CH | 1 |
| Teasley, JE | 1 |
| Rigamonti, A | 1 |
| Lauria, G | 1 |
| Balgera, R | 1 |
| Agostoni, E | 1 |
| Hu, JY | 1 |
| Chen, JL | 1 |
| Zhang, ZH | 1 |
| Pavesi, G | 1 |
| Cattaneo, L | 1 |
| Marbini, A | 1 |
| Gemignani, F | 1 |
| Mancia, D | 1 |
| Haq, RU | 1 |
| Pendlebury, WW | 1 |
| Fries, TJ | 1 |
| Tandan, R | 1 |
| Kissel, JT | 1 |
| Magda, P | 1 |
| Latov, N | 1 |
| Brannagan, TH | 1 |
| Weimer, LH | 1 |
| Chin, RL | 1 |
| Sander, HW | 1 |
| Hengstman, GJ | 1 |
| Schelhaas, HJ | 1 |
| Zwarts, MJ | 1 |
| Henderson, RD | 2 |
| Sandroni, P | 1 |
| Wijdicks, EF | 1 |
| Sivakumar, K | 1 |
| Fife, TD | 1 |
| Siman-Tov, T | 1 |
| Meiner, V | 1 |
| Gadoth, N | 1 |
| Celik, Y | 1 |
| Turgut, N | 1 |
| Turgut, B | 1 |
| Pamuk, GE | 1 |
| Demir, M | 1 |
| Mazzucco, S | 1 |
| Ferrari, S | 1 |
| Mezzina, C | 1 |
| Tomelleri, G | 1 |
| Bertolasi, L | 1 |
| Rizzuto, N | 1 |
| Rossignol, E | 1 |
| D'Anjou, G | 1 |
| Lapointe, N | 1 |
| Haddad, E | 1 |
| Vanasse, M | 1 |
| Maisonobe, T | 1 |
| Jaccard, A | 1 |
| Valenzise, M | 1 |
| Meloni, A | 1 |
| Betterle, C | 1 |
| Giometto, B | 1 |
| Autunno, M | 1 |
| Mazzeo, A | 1 |
| Cao, A | 1 |
| De Luca, F | 1 |
| Healy, HG | 1 |
| McCombe, PA | 1 |
| Lander, CM | 1 |
| Sghirlanzoni, A | 1 |
| Solari, A | 1 |
| Ciano, C | 1 |
| Mariotti, C | 1 |
| Fallica, E | 1 |
| Pareyson, D | 1 |
| Miyamoto, K | 1 |
| Oka, N | 1 |
| Kawasaki, T | 1 |
| Akiguchi, I | 1 |
10 reviews available for prednisone and Chronic Inflammatory Demyelinating Polyradiculoneuropathy
| Article | Year |
|---|---|
Immunotherapy for Peripheral Nerve Disorders.
Topics: Adrenal Cortex Hormones; Aged; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunother | 2021 |
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Dexamethasone; Glucocorticoids; Humans; Polyradiculoneuropathy, Chronic In | 2017 |
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Dexamethasone; Glucocorticoids; Humans; Polyradiculoneuropathy, Chronic In | 2015 |
Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
Topics: Adrenal Cortex Hormones; Azathioprine; Dexamethasone; Humans; Immunoglobulins, Intravenous; Immunosu | 2017 |
Initial treatment of childhood chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Adrenal Cortex Hormones; Adult; Child; Cyclophosphamide; Humans; Immunoglobulins, Intravenous; Immun | 2008 |
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Dexamethasone; Glucocorticoids; Humans; Polyradiculoneuropathy, Chronic In | 2012 |
The treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Polyradicu | 2003 |
Chronic inflammatory demyelinating polyneuropathy in childhood.
Topics: Anti-Inflammatory Agents; Child, Preschool; Diagnosis, Differential; Female; Humans; Immunoglobulins | 2001 |
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Humans; Polyradiculoneuropathy, Chronic Inflammat | 2001 |
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Humans; Polyradiculoneuropathy, Chronic Inflammat | 2002 |
2 trials available for prednisone and Chronic Inflammatory Demyelinating Polyradiculoneuropathy
| Article | Year |
|---|---|
[Clinical observation on treatment of 10 patients with chronic inflammatory demyelinating polyneuropathy by gullong tongluo capsule combined with prednisone].
Topics: Adolescent; Adult; Drugs, Chinese Herbal; Female; Humans; Male; Medicine, Chinese Traditional; Middl | 2009 |
Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Child; Cyclophosphamide; Electrophy | 2000 |
27 other studies available for prednisone and Chronic Inflammatory Demyelinating Polyradiculoneuropathy
| Article | Year |
|---|---|
Efficacy of long-term prednisone therapy in patients with chronic inflammatory demyelinating polyneuropathy (CIDP): a retrospective cohort study.
Topics: Adult; Cohort Studies; Female; Glucocorticoids; Humans; Male; Middle Aged; Polyradiculoneuropathy, C | 2021 |
Chronic inflammatory demyelinating polyradiculoneuropathy secondary to immune checkpoint inhibitors in melanoma patients.
Topics: Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Female; | 2019 |
A case of combined central and peripheral demyelination in Zambia.
Topics: Adult; Azathioprine; Comorbidity; Demyelinating Diseases; Developing Countries; Glucocorticoids; Hum | 2020 |
Pulse oral corticosteroids in pediatric chronic inflammatory demyelinating polyneuropathy.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Child; Child, Preschool; Duration of Ther | 2020 |
Onset of fulminant type 1 diabetes mellitus under immunotolerance status after long-term therapy for chronic inflammatory demyelinating polyneuropathy.
Topics: Diabetes Mellitus, Type 1; Glucocorticoids; Humans; Immunization, Passive; Male; Methylprednisolone; | 2018 |
Diagnosing chronic inflammatory demyelinating polyradiculoneuropathy with triple stimulation technique.
Topics: Administration, Oral; Adult; Aged; Disability Evaluation; Electrodiagnosis; Female; Glucocorticoids; | 2018 |
Corticosteroids in chronic inflammatory demyelinating polyneuropathy : A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone.
Topics: Adrenal Cortex Hormones; Bendamustine Hydrochloride; Dexamethasone; Female; Follow-Up Studies; Human | 2018 |
New onset psoriasis in a patient with chronic inflammatory demyelinating polyneuropathy treated with Rituximab.
Topics: Adult; Combined Modality Therapy; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immu | 2020 |
Bisphosphonate-induced orbital inflammation in a patient on chronic immunosuppressive therapy.
Topics: Administration, Oral; Bone Density Conservation Agents; Cyclosporine; Female; Glucocorticoids; Human | 2019 |
Chronic inflammatory demyelinating polyradiculoneuropathy: in a remote northern Ontario hospital.
Topics: Aged; Electromyography; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; | 2013 |
Monophasic CIDP Associated with Autoimmune Hemolytic Anemia.
Topics: Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Glucocorticoids; Humans; Male; Polyradiculoneuropa | 2014 |
Chronic inflammatory demyelinating polyneuropathy associated with neurosyphilis.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Biopsy; Cognitive Dysfunction; Electromyography; Ex | 2015 |
Subacute inflammatory polyradiculopathy associated with Sjögren's syndrome.
Topics: Aged; Disease Progression; Electrodiagnosis; Female; Humans; Immunosuppressive Agents; Magnetic Reso | 2009 |
Long-term efficacy of interferon-alpha in chronic inflammatory demyelinating polyneuropathy.
Topics: Axons; Azathioprine; Cyclophosphamide; Disease Progression; Drug Administration Schedule; Female; Hu | 2002 |
Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
Topics: Adjuvants, Immunologic; Adult; Azathioprine; Diabetic Neuropathies; Female; Humans; Immunoglobulins, | 2003 |
Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.
Topics: Action Potentials; Adult; Aged; Cohort Studies; Disability Evaluation; Electrodiagnosis; Female; Glu | 2003 |
Auditory dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Acute Disease; Aged; Anti-Inflammatory Agents; Evoked Potentials, Auditory, Brain Stem; Functional L | 2004 |
Chronic inflammatory demyelinating polyneuropathy and respiratory failure.
Topics: Aged; Azathioprine; Biopsy; Coma; Cyclophosphamide; Electromyography; Female; Follow-Up Studies; Hum | 2005 |
Autoimmune hearing loss in chronic inflammatory demyelinating polyneuropathy.
Topics: Adult; Anti-Inflammatory Agents; Autoantibodies; Cochlea; Female; Hair Cells, Auditory; Hearing Loss | 2005 |
Could steroids mask the diagnosis of cerebrotendinous xanthomatosis?
Topics: Achilles Tendon; Adult; Brain; Chenodeoxycholic Acid; Cholestanetriol 26-Monooxygenase; Cholestanol; | 2006 |
Chronic idiopathic demyelinating polyneuropathy (CIDP) associated with Kaposi's sarcoma.
Topics: Aged; Anti-Inflammatory Agents; Electromyography; Female; Humans; Polyradiculoneuropathy, Chronic In | 2006 |
Hyperpyrexia-triggered relapses in an unusual case of ataxic chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Ataxia; Electromyography; Fever; Humans; Immunoglobulins, Intravenous; Imm | 2006 |
Evolution and treatment of childhood chronic inflammatory polyneuropathy.
Topics: Acute Disease; Adolescent; Azathioprine; Child; Child, Preschool; Disease Progression; Female; Gluco | 2007 |
[Chronic inflammatory demyelinating polyneuropathy (CIDP) revealing an associated disease diagnostic and therapeutic pitfalls].
Topics: Anti-Infective Agents; Electrodiagnosis; Humans; Hypertrichosis; Male; Median Nerve; Middle Aged; Mo | 2007 |
Chronic inflammatory demyelinating polyneuropathy as a possible novel component of autoimmune poly-endocrine-candidiasis-ectodermal dystrophy.
Topics: Administration, Oral; Adolescent; AIRE Protein; Alleles; Biopsy; DNA Mutational Analysis; Electromyo | 2009 |
Chronic inflammatory demyelinating polyradiculoneuropathy and severe peripheral oedema: a renal explanation.
Topics: Anti-Inflammatory Agents; Edema; Glomerulosclerosis, Focal Segmental; Humans; Kidney Glomerulus; Mal | 2000 |
A case of chronic inflammatory demyelinating polyneuropathy with antigalactocerebroside antibody.
Topics: Activities of Daily Living; Adult; Autoantibodies; Cerebrospinal Fluid Proteins; Electrophysiology; | 2000 |